Ligand validation:4RL8

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 4RL8 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Model completeness	Average occupancy
4RL8_C8E_A_307	28%	88%	0.184	0.895	0.38	0.29	-	-	0	67%	0.6667
4RL8_C8E_B_301	28%	85%	0.159	0.903	0.4	0.35	-	-	1	48%	0.4762
4RL8_C8E_B_302	27%	83%	0.16	0.843	0.35	0.42	-	-	3	81%	0.8095
4RL8_C8E_A_308	27%	88%	0.142	0.884	0.32	0.35	-	-	1	48%	0.4762
4RL8_C8E_A_303	25%	86%	0.146	0.881	0.37	0.34	-	-	0	43%	0.4286
4RL8_C8E_C_304	21%	82%	0.201	0.846	0.33	0.47	-	-	0	81%	0.8095
4RL8_C8E_C_303	21%	78%	0.21	0.906	0.36	0.51	-	-	0	52%	0.5238
4RL8_C8E_B_304	20%	88%	0.211	0.917	0.35	0.31	-	-	0	43%	0.4286
4RL8_C8E_A_301	19%	91%	0.174	0.878	0.38	0.21	-	-	1	38%	0.381
4RL8_C8E_B_303	19%	89%	0.265	0.902	0.4	0.24	-	-	1	76%	0.7619
4RL8_C8E_C_306	18%	77%	0.167	0.849	0.33	0.58	-	-	0	48%	0.4762
4RL8_C8E_D_305	18%	82%	0.178	0.842	0.33	0.47	-	-	1	57%	0.5714
4RL8_C8E_D_303	18%	85%	0.181	0.857	0.4	0.34	-	-	1	48%	0.4762
4RL8_C8E_A_309	17%	83%	0.167	0.837	0.31	0.46	-	-	3	48%	0.4762
4RL8_C8E_A_310	16%	85%	0.171	0.835	0.33	0.41	-	-	1	48%	0.4762
4RL8_C8E_A_304	16%	84%	0.196	0.834	0.47	0.29	-	-	0	62%	0.619
4RL8_C8E_D_307	15%	86%	0.188	0.829	0.42	0.29	-	-	0	52%	0.5238
4RL8_C8E_B_305	14%	83%	0.185	0.805	0.38	0.39	-	-	0	62%	0.619
4RL8_C8E_D_304	13%	83%	0.26	0.934	0.48	0.3	-	-	0	29%	0.2857
4RL8_C8E_A_305	12%	89%	0.229	0.898	0.29	0.36	-	-	0	24%	0.2381
4RL8_C8E_D_301	12%	80%	0.216	0.822	0.32	0.51	-	-	2	57%	0.5714
4RL8_C8E_D_306	10%	86%	0.246	0.8	0.38	0.33	-	-	0	71%	0.7143
4RL8_C8E_C_302	10%	89%	0.231	0.793	0.42	0.23	-	-	0	67%	0.6667
4RL8_C8E_C_305	10%	83%	0.262	0.84	0.4	0.38	-	-	1	57%	0.5714
4RL8_C8E_A_302	8%	90%	0.224	0.832	0.3	0.29	-	-	0	24%	0.2381
4RL8_C8E_A_306	7%	78%	0.226	0.782	0.5	0.38	-	-	0	48%	0.4762
4RL8_C8E_C_301	6%	81%	0.285	0.781	0.39	0.43	-	-	0	67%	0.6667
4RL8_C8E_D_302	3%	85%	0.324	0.807	0.29	0.45	-	-	0	24%	0.2381
5FOK_C8E_A_1725	80%	74%	0.099	0.949	0.47	0.53	-	-	2	100%	1
6EHD_C8E_A_409	64%	60%	0.105	0.903	0.41	1.08	-	2	3	100%	1
5MDO_C8E_B_404	61%	73%	0.118	0.908	0.36	0.65	-	-	0	100%	1
5DL7_C8E_A_506	61%	47%	0.123	0.912	0.72	1.34	-	3	4	100%	1
6HCP_C8E_C_824	59%	77%	0.116	0.924	0.46	0.46	-	-	1	86%	0.8571

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.

Prepare Data

Validate Data

Deposit Data

Help and Resources

4RL8

C8E: (HYDROXYETHYLOXY)TRI(ETHYLOXY)OCTANE

C8E is a Ligand Of Interest in 4RL8 designated by the RCSB